Takeda Pharmaceutical Company Limited announced on
July 1, 2008 that Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc. merged with TAP Pharmaceutical Products Inc. (TAP), forming one of the top 15 pharmaceutical companies in the United States.

The merger is a result of the conclusion of a 30-year joint venture between Takeda Pharmaceutical Company Limited and Abbott announced March 19, 2008. According to terms previously announced, Takeda received the rights to TAP’s product Prevacid, its non-Lupron related commercial organization, TAP's support organizations, and TAP’s pipeline.

Thank you for visiting. To access the site in the future, please go directly to www.tpna.com.